| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 8 | |
| #2 | Germany | 6 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Canada | 4 | |
| #5 | United States | 2 | |
| #6 | Serbia | 1 | |
| #7 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Microbiology | |
| #5 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Blaschke Ulrich Kurt | 10 |
| #2 | Hesse Jan-Ole | 10 |
| #3 | Mack Michael | 10 |
| #4 | Schumann Christof | 10 |
| #5 | Schaeffner Joerg | 5 |
| #6 | Dietrich Arndt | 5 |
| #7 | Janowski Bernhard | 5 |
| #8 | Hakemeyer Christian | 3 |
| #9 | Lehmann Juergen | 3 |
| #10 | Luetkemeyer Dirk | 3 |
| Publication | Filing date | Title |
|---|---|---|
| DE102006009437A1 | G-CSF liquid formulation | |
| DE102005033250A1 | Process for purifying G-CSF | |
| DE102004041639A1 | Method for obtaining biologically active human G-CSF from inclusion bodies | |
| DE102004027816A1 | Process for the purification of erythropoietin | |
| DE102004011663A1 | Erythropoietin liquid formulation | |
| DE102004007658A1 | Process for the production of recombinant proteins in eukaryotic host cells | |
| EP1428878A1 | Process for the production and purification of erythropoietin |